United States

On August 13, 2026, the FDA granted accelerated approval to iberdomide (Zenbexus), the first cereblon E3 ligase modulator (CELMoD), in combination with daratumumab, hyaluronidase-fihj, and dexamethaso...

The SEC cancelled, via a Sunshine Act notice, its previously scheduled August 14, 2026 open meeting at which the Commission would have considered proposing new rules to create a tailored offering regi...

President Trump signed a proclamation on August 13, 2026 imposing tiered Section 232 tariffs on unmanned aircraft systems (UAS/drones) and their components, citing national security risk from foreign-...

The FTC and Illinois Attorney General distributed 640,038 payments totaling more than $23.8 million to Grubhub drivers and diners, stemming from a late-2024 $25 million settlement over allegations Gru...

FDA proposed converting its decades-old voluntary GRAS (Generally Recognized as Safe) notification program into a mandatory one, requiring manufacturers to notify the agency whenever they independentl...

The CFTC filed a complaint in the U.S. District Court for the Middle District of Florida against Goliath Ventures Inc. and its CEO Christopher Delgado, alleging a Ponzi scheme that fraudulently solici...

The CFTC exercised its emergency authority under the Commodity Exchange Act to order KalshiEX, LLC to continue operating in accordance with the Act's Core Principles, after KalshiEX notified the Commi...

At the FTC's request, a federal court in Arizona temporarily halted Credit Glory, a network of 16 related companies and five principals accused of scamming consumers out of nearly $200 million since a...

Chairman Michael Selig announced the inaugural meeting of the CFTC's Innovation Advisory Committee, formerly the Technology Advisory Committee, to be held August 20, 2026 in Washington, D.C. and lives...

The FTC voted 2-0 to approve a policy statement declaring the Commission will no longer pursue claims based on disparate-impact or 'unfair discrimination' theories, which the agency said presume unlaw...